1. Ownership: CLL is co-founder and chief scientific officer of Shift Pharmaceuticals. 2. Income: CLL has received in excess of $10,000 in income per annum from Shift Pharmaceuticals. 3. Research support. Research in the CLL and MAL labs have been supported by subawards from Shift Pharmaceuticals (as part of grants from the DOD, CMT Research Foundation and the NIH). 4. Intellectual property. CLL and MU share patents on novel compounds licensed by Shift Pharmaceuticals and planned patents for additional novel compounds. MAL and ZCL are associated with Shift by family relation. SAH was formerly employed by Shift Pharmaceuticals. KS is chief scientific officer for Sanctum Therapeutics Corporation. 1. Ownership: KS is chief scientific officer of Sanctum Therapeutics Corporation. 2. Income: KS has received in excess of $10,000 in income per annum from Sanctum Therapeutics Corporation. 3. Intellectual property. KS and MU share patents on novel compounds licensed by Sanctum Therapeutics Corporation and planned patents for additional novel compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.